journal article·2025-02Open access

Recent development of micro-nano carriers for oral antineoplastic drug delivery

Hongzheng Li, Xiang Chen, Shangrui Rao, Minyu Zhou, Jianhua Lu, Danna Liang, Bingzi Zhu, Letian Meng, Ji Lin, Xiaoya Ding, Qingfei Zhang, Danhong Hu

Abstract

Chemotherapy is widely recognized as a highly efficacious modality for cancer treatment, involving the administration of chemotherapeutic agents to target and eradicate tumor cells. Currently, oral administration stands as the prevailing and widely utilized method of delivering chemotherapy drugs. However, the majority of anti-tumor medications exhibit limited solubility and permeability, and poor stability in harsh gastrointestinal environments, thereby impeding their therapeutic efficacy for chemotherapy. Therefore, more and more micro-nano drug delivery carriers have been developed and used to effectively deliver anti-cancer drugs, which can overcome physiological barriers, facilitate oral administration, and ultimately improve drug efficacy. In this paper, we first discuss the effects of various biological barriers on micro-nano drug carriers and oral administration approach. Then, the development of micro-nano drug carriers based on various biomedical components, such as micelles, dendrimers, hydrogels, liposomes, inorganic nanoparticles, etc. were introduced. Finally, the current dilemma and the potential of oral drug delivery for clinical treatment were discussed. The primary objective of this review is to introduce various oral delivery methods and serve as a point of reference for the advancement of novel oral delivery carriers, with the ultimate goal of informing the development of future clinical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients10.1007/s002800050043 ↗
2. Biotransformation of the platinum drug JM216 following oral administration to cancer patients10.1007/s002800050464 ↗
3. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer
4. Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism10.1007/BF01059061 ↗
5. Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism10.1016/S0009-9236(96)90177-0 ↗
6. Gut wall metabolism. Application of pre-clinical models for the prediction of human drug absorption and first-pass elimination10.1208/s12248-016-9889-y ↗
7. First-pass elimination basic concepts and clinical consequences10.2165/00003088-198409010-00001 ↗
8. Development and characterization of stimuli-responsive hydrogel microcarriers for oral protein delivery10.1002/jbm.a.36030 ↗
9. Interaction between porous silica gel microcarriers and peptides for oral administration of functional peptides10.1038/s41598-018-29345-2 ↗
10. Self-assembly of Zein-based microcarrier system for colon-targeted oral drug delivery10.1021/acs.iecr.8b02092 ↗
11. In vivo gastrointestinal drug-release monitoring through second near-infrared window fluorescent bioimaging with orally delivered microcarriers
12. Oral biomaterials for intestinal regulation10.1016/j.engreg.2021.09.002 ↗
13. Ultrasound-trigged micro/nanorobots for biomedical applications
14. Developing biomedical engineering technologies for reproductive medicine10.1002/SMMD.20220006 ↗
15. Cell‐based drug delivery and use of nano‐and microcarriers for cell functionalization
16. Past, present, and future of microcarrier-based tissue engineering10.1016/j.jot.2015.02.003 ↗
17. Evaluation of nano-and microparticle uptake by the gastrointestinal tract10.1016/S0169-409X(98)00041-6 ↗
18. Microfluidic electrospray photo-crosslinkable κ-Carrageenan microparticles for wound healing10.1016/j.engreg.2021.10.002 ↗
19. Metal-organic framework (MOF)-based biomaterials in bone tissue engineering10.1016/j.engreg.2021.09.001 ↗
20. The role of mixed micelles in drug delivery. I. Solubilization10.3109/03639049809082372 ↗
21. Pyrene solubilization in aqueous micellar solutions of pluronic block copolymers
22. Successful entrapping of liposomes in glucan particles: an innovative micron-sized carrier to deliver water-soluble molecules10.1021/mp500374f ↗
23. Biopolymer lipid hybrid microcarrier for transmembrane inner ear delivery of dexamethasone10.3390/gels8080483 ↗
24. Multilayered curcumin-loaded hydrogel microcarriers with antimicrobial function10.3390/molecules27041415 ↗
25. Responsive graphene oxide hydrogel microcarriers for controllable cell capture and release10.1007/s40843-018-9251-9 ↗
26. Breathable, stretchable and adhesive nanofibrous hydrogels as wound dressing materials10.1016/j.engreg.2021.05.001 ↗
27. Design of flexible dendrimer-grafted flower-like magnetic microcarriers for penicillin G acylase immobilization10.1007/s10853-017-1581-9 ↗
28. Magnetic polyurethane microcarriers from nanoparticle-stabilized emulsions for thermal energy storage10.1021/acssuschemeng.0c05525 ↗
29. Reactions in double emulsions by flow-controlled coalescence of encapsulated drops10.1039/c1lc20265k ↗
30. Photonic crystal hydrogel beads used for multiplex biomolecular detection10.1039/b906652g ↗
31. Liquid metal-integrated ultra-elastic conductive microfibers from microfluidics for wearable electronics10.1016/j.scib.2020.06.002 ↗
32. Microfluidic generation of microsprings with ionic liquid encapsulation for flexible electronics10.34133/2019/6906275 ↗
33. A review: micro carrier as colon drug delivery system
34. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice10.1038/s41467-019-09760-3 ↗
35. Flexible hemline-shaped microfibers for liquid transport10.1038/s44286-023-00001-5 ↗
36. Recent trends in oral drug delivery: a review10.2174/187221109788452267 ↗
37. Strategies to improve oral drug bioavailability10.1517/17425247.2.3.419 ↗
38. The intestinal epithelial barrier: does it become impaired with age?10.1159/000228556 ↗
39. The intestinal barrier function and its involvement in digestive disease
40. Kokate · 2006 · 41
41. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?10.2165/00003088-200241040-00001 ↗
42. Materials for oral delivery of proteins and peptides10.1038/s41578-019-0156-6 ↗
43. Small intestine
44. Barrier properties of mucus10.1016/j.addr.2008.09.008 ↗
45. Gastrointestinal device-mediated delivery of mRNA-lipid nanoparticles achieves distinct expression and biodistribution in mice and pigs10.1021/acsami.4c11819 ↗
46. Drug delivery: pH and reactive oxygen species-sequential responsive nano-in-micro composite for targeted therapy of inflammatory bowel disease (adv. Funct. Mater. 50/2018)
47. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment10.1016/j.carbpol.2021.117998 ↗
48. Cell-mediated biointerfacial phenolic assembly for probiotic nano encapsulation10.1002/adfm.202200775 ↗
49. Novel nano-encapsulated probiotic agents: encapsulate materials, delivery, and encapsulation systems10.1016/j.jconrel.2022.06.061 ↗
50. Synthetic lignin-derived therapeutic nano reagent as intestinal pH-sensitive drug carriers capable of bypassing the gastric acid environment for colitis treatment10.1021/acsnano.2c11188 ↗
51. Oral polyphenol-armored nanomedicine for targeted modulation of gut microbiota-brain interactions in colitis10.1126/sciadv.adf3887 ↗
52. Colon-targeted adhesive hydrogel microsphere for regulation of gut immunity and flora
53. Combining gut microbiota modulation and enzymatic-triggered colonic delivery by prebiotic nanoparticles improves mouse colitis therapy10.34133/bmr.0062 ↗
54. Advances in oral drug delivery10.3389/fphar.2021.618411 ↗
55. Surfactant proteins in the digestive tract, mesentery, and other organs: evolutionary significance10.1016/S1095-6433(01)00312-9 ↗
56. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems10.1186/s12951-022-01539-x ↗
57. Oral administration of multistage albumin nanomedicine depots (MANDs) for targeted efficient alleviation of chronic inflammatory diseases10.1002/adfm.202211644 ↗
58. Synergistic combination of oral transcytotic nanomedicine and histone demethylase inhibitor for enhanced cancer chemoimmunotherapy10.1021/acsnano.4c14816 ↗
59. A novel strategy for visualizing, tracing, and measuring the gastrointestinal absorption of silver nanoparticles10.1002/adfm.202302366 ↗
60. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics10.1186/s12951-021-00770-2 ↗
61. Pharmaceutical nanoparticles and the mucin biopolymer barrier
62. Intestinal distribution of anionic, cationic, and neutral polymer-stabilized nanocarriers measured with a lanthanide (europium) tracer assay10.1016/j.jconrel.2024.10.006 ↗
63. Natural gastrointestinal stable pea albumin nanomicelles for capsaicin delivery and their effects for enhanced mucus permeability at small intestine10.34133/bmr.0065 ↗
64. The intestinal epithelial barrier: a therapeutic target?10.1038/nrgastro.2016.169 ↗
65. The intestinal epithelial barrier in the control of homeostasis and immunity10.1016/j.it.2011.04.003 ↗
66. Transcellular uptake mechanisms of the intestinal epithelial barrier Part one, Pharmaceutical science & technology
67. Rational design of oral drugs targeting mucosa delivery with gut organoid platforms
68. Molecular modulation of intestinal epithelial barrier: contribution of microbiota10.1155/2010/305879 ↗
69. How do polymeric micelles cross epithelial barriers?10.1016/j.ejps.2013.04.012 ↗
70. Prebiotics and postbiotics synergistic delivery microcapsules from microfluidics for treating colitis10.1002/advs.202104089 ↗
71. Glycyrrhetinic acid liposomes encapsulated microcapsules from microfluidic electrospray for inflammatory wound healing10.1002/adfm.202304353 ↗
72. Tailored polymersomes for enhanced oral drug delivery: pH-sensitive systems for intestinal delivery of immunosuppressants
73. A new strategy for intestinal drug delivery via pH-responsive and membrane-active nanogels10.1021/acsami.8b15661 ↗
74. Reinforcement of the intestinal mucosal barrier via mucus-penetrating PEGylated bacteria10.1038/s41551-024-01224-4 ↗
75. PEGylation for enhancing nanoparticle diffusion in mucus10.1016/j.addr.2017.08.010 ↗
76. Diffusion of macromolecules and virus-like particles in human cervical mucus10.1016/S0006-3495(01)75844-4 ↗
77. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus10.1073/pnas.0608611104 ↗
78. Oral peptide delivery: translational challenges due to physiological effects10.1016/j.jconrel.2018.08.032 ↗
79. The enhancement of N-acetylcysteine on intestinal absorption and oral bioavailability of hydrophobic curcumin10.1016/j.ejps.2020.105506 ↗
80. Overcoming multiple absorption barrier for insulin oral delivery using multifunctional nanoparticles based on chitosan derivatives and hyaluronic acid10.2147/IJN.S251627 ↗
81. OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential impact of the polyethylene glycol linker size on drug delivery in vitro, in situ, and in vivo10.1080/10717544.2019.1710623 ↗
82. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery10.1016/j.biomaterials.2017.10.022 ↗
83. Foundations of gastrointestinal-based drug delivery and future developments10.1038/s41575-021-00539-w ↗
84. Current updated review on preparation of polymeric nanoparticles for drug delivery and biomedical applications
85. Polymeric micro/nanoparticles: particle design and potential vaccine delivery applications10.1016/j.vaccine.2015.07.100 ↗
86. Advanced polymeric solids containing nano- and micro-particles prepared via emulsion-based polymerization approaches. A review10.1016/j.aca.2022.339669 ↗
87. Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation10.1016/j.carbpol.2013.05.091 ↗
88. Internal distribution of micro-/nano-sized inorganic particles and their cytocompatibility10.1088/1757-899X/18/19/192013 ↗
89. In vivo internal diffusion of several inorganic microparticles through oral administration
90. Dielectrophoresis for manipulation of micro/nano particles in microfluidic systems10.1007/s00216-009-2922-6 ↗
91. Microfluidic synthesis of functional inorganic micro-/nanoparticles and applications in biomedical engineering10.1080/09506608.2018.1434452 ↗
92. Polymeric micelles in cancer therapy: state of the art10.1016/j.jconrel.2021.02.016 ↗
93. Polymeric micelles for nano-scale drug delivery10.1016/j.reactfunctpolym.2010.10.009 ↗
94. A review of polymeric micelles and their applications10.3390/polym14122510 ↗
95. Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel10.1208/s12249-011-9636-8 ↗
96. Chapter 3 - lipid-based nanoparticles for drug delivery systems
97. Polymeric biomaterial and lipid based nanoparticles for oral drug delivery10.2174/0929867323666161028160004 ↗
98. pH-responsive multi-network composite cellulose-based hydrogels for stable delivery of oral IgY-Fab fragments10.1016/j.foodchem.2023.137567 ↗
99. Magnetic multilayer hydrogel oral microrobots for digestive tract treatment10.3389/frobt.2024.1392297 ↗
100. Advances on hydrogels for oral science research10.3390/gels8050302 ↗